Nexalin Technology NXL
NASDAQ NXL
$5.73 -1.82 (-24.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

Nexalin Technology (NXL) recorded Return on Capital Employed [ROCE] of -489.42% in Q2 2026, down 271.19 percentage points from -218.23% a year earlier and down 236.20 percentage points from the prior quarter.

Analysis

Nexalin Technology (NXL) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, Nexalin Technology reported Return on Capital Employed [ROCE] of -236.92%, down 7.53 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three straight years, with a three-year change of -151.42 percentage points (FY2022 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -229.38% in FY2024 (-117.84 pp), -111.54% in FY2023 (-26.05 pp) and -85.50% in FY2022.
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2022.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in three of the last eight quarters, with an average year-over-year change of -35.11 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 104.48 percentage points in Q2 2025, against a drop of 271.19 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -253.22% (Q1 2026), -210.12% (Q4 2025) and -161.33% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 7.98%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 18.58%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.34%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 13.69%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 6.00%
10 Nexalin Technology 4.20 Mn -7.59 Mn 8,897.00 -489.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -489.42%
Mar 31, 2026 -253.22%
Dec 31, 2025 -210.12%
Sep 30, 2025 -161.33%
Jun 30, 2025 -218.23%
Mar 31, 2025 -291.03%
Dec 31, 2024 -184.93%
Sep 30, 2024 -209.07%
Jun 30, 2024 -322.71%
Mar 31, 2024 -219.77%
Dec 31, 2023 -157.90%
Sep 30, 2023 -132.81%
Jun 30, 2023 -61.07%
Mar 31, 2023 -40.78%
Dec 31, 2022 -30.84%
API Access

Nexalin Technology Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NXL&period=max&api_key=YOUR_API_KEY